US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist
  • 8.490
  • -0.120-1.39%
Close Feb 28 16:00 ET
  • 8.500
  • +0.010+0.12%
Post 18:52 ET
496.77MMarket Cap-3.05P/E (TTM)

Cullinan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cullinan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Cullinan Therapeutics Earnings Reports

  • Cullinan Therapeutics | 10-K: Annual report

    Feb 27 07:07 ET

  • Cullinan Therapeutics | 8-K: Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

    Feb 27 07:03 ET

  • Cullinan Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 07:23 ET

  • Cullinan Therapeutics | 8-K: Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

    Nov 7, 2024 07:08 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data